Ribosomal DNA Copy Numbers Decrease in Some Cancers

An analysis of human cancer genome projects uncovers a counterintuitive loss of ribosomal gene copies.

Written byAbby Olena, PhD
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Human chromosomes stained blue and ribosomal DNA in greenTAMARA POTAPOVA (WITH PERMISSION)Ribosomal DNA (rDNA) is highly repetitive, making it tough for scientists to analyze. But a new study, published today (June 22) in PLOS Genetics, reveals that the genomes of cancer cells in both humans and mice have fewer copies of rDNA genes than their normal counterparts. Yet despite this loss, mice show more ribosomal RNA and protein synthesis.

“This is the first comprehensive, in-depth analysis of ribosomal DNA copy number in human cancers,” says Mikael Linström, a cancer biologist at the Karolinska Institute in Sweden who did not participate in the work. “In all labs that are working with ribosome biogenesis and rDNA genes, the question is always: what’s the role of the mysterious rDNA?”

Coauthor Jennifer Gerton, a yeast biologist at the Stowers Institute for Medical Research in Kansas City, Missouri, says that the inspiration to look at rDNA in cancer genomes came from work in yeast and human cells that has shown highly variable copy numbers in rDNA genes. She was curious to see how that variability fared in the context of cancer.

Gerton and colleagues analyzed whole genome sequencing data ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies